Lauren Merendino, Chief Commercial Officer at Day One Biopharmaceuticals, Inc. (DAWN), sold 11,628 shares at $11.60 ($135K) on 2026-02-17, disclosed to the SEC on 2026-02-18.
Open-market sale of $135k DAWN by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.60 | 5,814 | $67K | 50.0% |
| 2 | $11.60 | 5,814 | $67K | 50.0% |
| Total | $11.60 avg | 11,628 | $135K | 100% |
| Filing → |
| DAWN | SELL | 2025-05-19 | $25K | — | Filing → |
| MYOV | SELL | 2023-01-20 | $108K | — | Filing → |
| MYOV | SELL | 2022-10-20 | $43K | — | Filing → |